Study of Two Titration Algorithms With Insulin Glargine 300 Units/mL in Type 2 Diabetes Mellitus Patients
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 253 participants.
Also called NCT02401243
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 253 participants
- Sponsor
- Registry
-
NCT02401243
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Canada
- Registry status
- Completed
Technical summary
Registry record NCT02401243. Randomized; no masking; primary purpose treatment. Start 2015-03 (registry gives no type); primary completion 2016-02 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Study of Two Titration Algorithms With Insulin Glargine 300 Units/mL in Type 2 Diabetes Mellitus Patients
- Acronym
- TITRATION
- Condition
- Type 2 Diabetes Mellitus
- Intervention (Drug)
- INSULIN GLARGINE (U300)
- Lead sponsor
- Sanofi
Record details
- Record id
cardio:ct-nct02401243- Content hash
a7930430ce9fb23d9e8b84c9c1ba9e97b3122d7bb9c6130bb9e4e995aceeae64